Table 2.
Immediate feedback and follow-up surveys: use and considerations of breast cancer risk-reducing activities
| Immediate feedback | ||||||
|---|---|---|---|---|---|---|
| Screening category | Pearson’s Chi-squared test (high vs. highest-risk participants) | |||||
| High (N = 221) | Highest (N = 97) | Total (N = 318) | Chi-square | p value | df | |
| Current risk-reducing activities | ||||||
| Use endocrine risk reduction | 7 (3.2%) | 8 (8.2%) | 15 (4.7%) | 2.8 | 0.09 | 1 |
| Decrease alcohol | 74 (33.5%) | 49 (50.5%)≠ | 123 (38.7%) | 7.5 | 0.006 | 1 |
| Increase exercise | 133 (60.2%) | 66 (68%) | 199 (62.6%) | 1.5 | 0.84 | 1 |
| Lose weight | 82 (37.1%) | 45 (46.4%) | 127 (39.9%) | N/A | N/A | N/A |
| Other | 14 (6.3%) | 12 (12.4%) | 26 (8.2%) | N/A | N/A | N/A |
| Nothing | 52 (23.5%) | 13 (13.4%) | 65 (20.4%) | N/A | N/A | N/A |
| Risk-reducing activities under consideration | ||||||
| Use endocrine risk reduction | 72 (32.6%) | 38 (39.2%) | 110 (34.6%) | 1.02 | 0.31 | 1 |
| Decrease alcohol | 33 (14.9%) | 14 (14.4%) | 47 (14.8%) | 9.5 × 10−30 | 1 | 1 |
| Increase exercise | 76 (34.4%) | 22 (22.7%) | 98 (30.8%) | 3.8 | 0.051 | 1 |
| Lose weight | 65 (29.4%) | 17 (17.5%) | 82 (25.8%) | N/A | N/A | N/A |
| Other | 14 (6.3%) | 3 (3.1%) | 17 (5.3%) | N/A | N/A | N/A |
| Nothing | 42 (19%) | 22 (22.7%) | 64 (20.1%) | N/A | N/A | N/A |
| Three-month follow-up | ||||||
|---|---|---|---|---|---|---|
| Current risk-reducing activities | Screening category | Pearson’s Chi-squared test (high vs. highest-risk participants) | ||||
| High (N = 72) | Highest (N = 37) | Total (N = 109) | Chi-square | p value | df | |
| Use endocrine risk reduction | 7 (9.7%) | 5 (13.5%) | 12 (11%) | 0.076 | 0.78 | 1 |
| Decrease alcohol | 26 (36.1%) | 16 (43.2%) | 42 (38.5%) | 0.27 | 0.6 | 1 |
| Increase exercise | 34 (47.2%) | 19 (51.4%) | 53 (48.6%) | 0.042 | 0.84 | 1 |
| Improve diet | 47 (65.3%) | 26 (70.3%) | 73 (67%) | N/A | N/A | N/A |
| Would like support services | 30 (41.7%) | 17 (45.9%) | 47 (43.1%) | N/A | N/A | N/A |
Current risk-reducing activities of participants as answered on the feedback survey, and risk reducing activities under consideration. Participants could select more than one activity, so percentages do not add up to 100. Percentages (%) calculated in each column according to column’s total N. High-risk participants were defined as yearly mammography screening assignments on the WISDOM Study. Highest risk participants were defined as every 6-month screening (alternating mammography and MRI) on the WISDOM Study. For statistical analysis, Pearson’s chi-squared test with Yates’ continuity correction was performed between high and highest-risk groups, with p values listed in the last column and ≠ designating statistical significance between the two groups.